Iridex (IRIX) Share-based Compensation (2011 - 2026)
Iridex (IRIX) posted Share-based Compensation of $212000.0 for Q3 2026, little changed on a QoQ basis from $211000.0 in Q2 2026, and down 17.51% year-over-year from $257000.0 in Q3 2025.
Powered by 
Analysis
Iridex (IRIX) Share-based Compensation (2011 - 2026) Analysis & Trends
Iridex has reported Share-based Compensation for 16 years, with the latest figure at $212000.0 in Q3 2026.
- On a quarterly basis, Share-based Compensation fell 17.51% year-over-year to $212000.0 in Q3 2026; TTM through Jul 2026 was $728000.0, a 19.11% decrease from a year earlier, with the FY2026 full-year figure at $775000.0, down 37.65% from the prior year.
- Share-based Compensation was $212000.0 for Q3 2026 at Iridex, roughly flat from $211000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $854000.0 in Q1 2022, with the low at $92000.0 in Q3 2025.
- Average Share-based Compensation over 5 years is $345578.9, with a median of $371000.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation rose 23.18% in 2023, then plunged 69.27% in 2024.
- Over 5 years, Share-based Compensation stood at $516000.0 in 2022, then retreated by 21.32% to $406000.0 in 2023, then dropped by 22.17% to $316000.0 in 2024, then tumbled by 70.89% to $92000.0 in 2025, then soared by 130.43% to $212000.0 in 2026.
- The last three Share-based Compensation figures came in at $212000.0 (Q3 2026), $211000.0 (Q2 2026), and $213000.0 (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Iridex | 11.85 Mn | 7.17 Mn | 4.30 Mn | 212,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 4, 2026 | 212,000.00 |
| Apr 4, 2026 | 211,000.00 |
| Jan 3, 2026 | 213,000.00 |
| Sep 27, 2025 | 92,000.00 |
| Jun 28, 2025 | 257,000.00 |
| Mar 29, 2025 | 213,000.00 |
| Dec 28, 2024 | 316,000.00 |
| Sep 28, 2024 | 114,000.00 |
| Jun 29, 2024 | 419,000.00 |
| Mar 30, 2024 | 394,000.00 |
| Dec 30, 2023 | 406,000.00 |
| Sep 30, 2023 | 371,000.00 |
| Jul 1, 2023 | 400,000.00 |
| Apr 1, 2023 | 473,000.00 |
| Dec 31, 2022 | 516,000.00 |
| Oct 1, 2022 | 377,000.00 |
| Jul 2, 2022 | 344,000.00 |
| Apr 2, 2022 | 384,000.00 |
| Jan 1, 2022 | 854,000.00 |
| Oct 2, 2021 | 617,000.00 |